Why a common herpes virus triggers a rare and complex form of cancer
In short: Kaposi sarcoma is a cancer of the blood and lymph vessel linings, driven by the human herpes virus 8. While healthy immune systems keep this virus dormant, it can trigger aggressive lesions in those with compromised immunity, such as people living with AIDS or those receiving organ transplant medications.
Kaposi sarcoma (KS) manifests as growths or lesions that typically appear on the skin as pink, red, purple, or brown patches. While often painless, these lesions can become disfiguring or interfere with bodily functions if they develop in the mouth, digestive tract, or lungs. The disease is caused by human herpes virus 8 (HHV-8), which is present in nearly all KS lesions. In healthy individuals, the immune system suppresses the virus, but when immunity is weakened, the virus can proliferate, leading to the formation of vascular channels that give the tumors their characteristic bruise-like appearance.
There are four primary types of KS, categorized by the patient's health status and geography. Epidemic or AIDS-related KS is common in people with HIV, while iatrogenic KS occurs in transplant recipients taking immunosuppressive drugs. Classic KS typically affects older men of Mediterranean, Eastern European, or Middle Eastern descent, usually progressing slowly. Endemic KS is most prevalent in sub-Saharan Africa, where it can affect children more aggressively. Though historically described by Moritz Kaposi in 1872, the causative role of HHV-8 was not confirmed until 1994.
Diagnosis often involves tissue biopsy, while treatment strategies vary based on the specific subtype and the extent of the disease. For localized skin lesions, doctors may use surgery, radiation, or chemotherapy injections. In patients with HIV, highly active antiretroviral therapy (HAART) is a primary tool for prevention and treatment. Because the virus is transmitted through saliva and blood, managing exposure is a key public health consideration. Despite its name, the condition is not considered a true sarcoma, and its exact histogenesis remains a subject of ongoing medical debate.
The complexity of the disease is highlighted by rare cases where primary manifestations occur in internal areas, such as the nasopharynx, without any visible skin involvement. Such cases underscore the diagnostic challenges clinicians face. While survival rates vary significantly depending on the subtype and whether the disease is localized or widespread, early detection and close communication with healthcare providers remain essential for managing this multifaceted condition.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Kaposi sarcoma - Symptoms and causes
- Also: Kaposi's sarcoma
To cite this card, link to https://intellectplus.co.uk/app/health-kaposi-s-sarcoma.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Morbidity · More in Health · Latest · A–Z · All topics